Induction of Mouse Melioidosis with Meningitis by CD11b+ Phagocytic Cells Harboring Intracellular B. pseudomallei as a Trojan Horse

PLoS Neglected Tropical Diseases

Volumn 7, Issue 8, 2013, Pages

  Liu, Pei Ju ^a   Chen, Yao Shen ^a,b,c   Lin, Hsi Hsu ^d   Ni, Wei Feng ^a   Hsieh, Tsung Han ^a   Chen, Hsu Tzu ^a   Chen, Ya Lei ^a  

^a NATIONAL KAOHSIUNG NORMAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d E DA HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CYTOKINE; LIVER ENZYME;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM COLONY; BONE MARROW; BRAIN; BURKHOLDERIA PSEUDOMALLEI; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; HISTOLOGY; LIVER; MELIOIDOSIS; MENINGITIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTE; PLASMID; SINGLE CELL ANALYSIS; SPLEEN; SUSPENSION CELL CULTURE;

EID: 84883343531     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002363     Document Type: Article

References (61)

1. Cheng AC, Currie BJ, (2005) Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 18: 383-416.
2. Dance DA, (2000) Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta Trop 74: 159-168.
3. West TE, Myers ND, Limmathurotsakul D, Liggitt HD, Chantratita N, et al. (2010) Pathogenicity of high-dose enteral inoculation of Burkholderia pseudomallei to mice. Am J Trop Med Hyg 83: 1066-1069.
4. Goodyear A, Bielefeldt-Ohmann H, Schweizer H, Dow S, (2012) Persistent gastric colonization with Burkholderia pseudomallei and dissemination from the gastrointestinal tract following mucosal inoculation of mice. PLoS One 7: e37324.
5. Cheng AC, (2010) Melioidosis: advances in diagnosis and treatment. Curr Opin Infect Dis 23: 554-559.
6. Liu B, Koo GC, Yap EH, Chua KL, Gan YH, (2002) Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect Immun 70: 504-511.
7. Srisurat N, Sermswan RW, Tatawasart U, Wongratanacheewin S, (2010) Bacterial loads and antibody responses in BALB/c mice infected with low and high doses of Burkholderia pseudomallei. Am J Trop Med Hyg 82: 1102-1105.
8. Hara Y, Mohamed R, Nathan S, (2009) Immunogenic Burkholderia pseudomallei outer membrane proteins as potential candidate vaccine targets. PLoS One 4: e6496.
9. Chen YS, Hsiao YS, Lin HH, Yen CM, Chen SC, et al. (2006) Immunogenicity and anti-Burkholderia pseudomallei activity in Balb/c mice immunized with plasmid DNA encoding flagellin. Vaccine 24: 750-758.
10. Hoppe I, Brenneke B, Rohde M, Kreft A, Häussler S, et al. (1999) Characterization of a murine model of melioidosis: comparison of different strains of mice. Infect Immun 67: 2891-2900.
11. Currie BJ, Ward L, Cheng AC, (2010) The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis 4: e900.
12. Muthusamy KA, Waran V, Puthucheary SD, (2007) Spectra of central nervous system melioidosis. J Clin Neurosci 14: 1213-1215.
13. Chou DW, Chung KM, Chen CH, Cheung BM, (2007) Bacteremic melioidosis in southern Taiwan: clinical characteristics and outcome. J Formos Med Assoc 106: 1013-1022.
14. Currie BJ, Fisher DA, Howard DM, Burrow JN, (2000) Neurological melioidosis. Acta Trop 74: 145-151.
15. White NJ, (2003) Melioidosis. Lancet 361: 1715-1722.
16. Thatrimontrichai A, Maneenil G, (2012) Neonatal Melioidosis: Systematic Review of the Literature. Pediatr Infect Dis J 31: 1195-1197.
17. Areekul S, Vongsthongsri U, Wattanarungson C, Cheattanadee S, Wilairatana P, (1997) Septicemic melioidosis and meningitis: a case report. Siriraj Hosp Gaz 49: 1084-1087.
18. Chlebicki MP, Kurup A, Sin YK, (2008) Burkholderia pseudomallei meningitis following inadequate treatment of melioidotic mycotic aneurysm. Singapore Med J 49: e219-221.
19. Barnes JL, Ulett GC, Ketheesan N, Clair T, Summers PM, (2001) Induction of multiple chemokine and colony-stimulating factor genes in experimental Burkholderia pseudomallei infection. Immunol Cell Biol 79: 490-501.
20. Thomas RJ, Davies C, Nunez A, Hibbs S, Eastaugh L, et al. (2012) Particle-size dependent effects in the Balb/c murine model of inhalational melioidosis. Front Cell Infect Microbiol 2: 101.
21. Santanirand P, Harley VS, Dance DA, Drasar BS, Bancroft GJ, (1999) Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun 67: 3593-3600.
22. Easton A, Haque A, Chu K, Lukaszewski R, Bancroft GJ, (2007) A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei. J Infect Dis 195: 99-107.
23. Laws TR, Smither SJ, Lukaszewski RA, Atkins HS, (2011) Neutrophils are the predominant cell-type to associate with Burkholderia pseudomallei in a BALB/c mouse model of respiratory melioidosis. Microb Pathog 51: 471-475.
24. Jones AL, Beveridge TJ, Woods DE, (1996) Intracellular survival of Burkholderia pseudomallei. Infect Immun 64: 782-790.
25. Bast A, Schmidt IH, Brauner P, Brix B, Breitbach K, et al. (2011) Defense Mechanisms of Hepatocytes Against Burkholderia pseudomallei. Front Microbiol 2: 277.
26. Charoensap J, Utaisincharoen P, Engering A, Sirisinha S, (2009) Differential intracellular fate of Burkholderia pseudomallei 844 and Burkholderia thailandensis UE5 in human monocyte-derived dendritic cells and macrophages. BMC Immunol 10: 20.
27. Kespichayawattana W, Rattanachetkul S, Wanun T, Utaisincharoen P, Sirisinha S, (2000) Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: a possible mechanism for cell-to-cell spreading. Infect Immun 68: 5377-5384.
28. French CT, Toesca IJ, Wu TH, Teslaa T, Beaty SM, et al. (2011) Dissection of the Burkholderia intracellular life cycle using a photothermal nanoblade. Proc Natl Acad Sci U S A 108: 12095-12100.
29. Breitbach K, Rottner K, Klocke S, Rohde M, Jenzora A, et al. (2003) Actin-based motility of Burkholderia pseudomallei involves the Arp 2/3 complex, but not N-WASP and Ena/VASP proteins. Cell Microbiol 5: 385-393.
30. Galyov EE, Brett PJ, DeShazer D, (2010) Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Annu Rev Microbiol 64: 495-517.
31. Conejero L, Patel N, de Reynal M, Oberdorf S, Prior J, et al. (2011) Low-dose exposure of C57BL/6 mice to Burkholderia pseudomallei mimics chronic human melioidosis. Am J Pathol 179: 270-280.
32. Engelhardt B, (2008) Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines. J Neurol Sci 274: 23-26.
33. Jaber SM, Hamed EA, Hamed SA, (2009) Adhesion molecule levels in serum and cerebrospinal fluid in children with bacterial meningitis and sepsis. J Pediatr Neurosci 4: 76-85.
34. Weiss N, Miller F, Cazaubon S, Couraud PO, (2009) The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 1788: 842-857.
35. Alexeyev MF, (1999) The pKNOCK series of broad-host-range mobilizable suicide vectors for gene knockout and targeted DNA insertion into the chromosome of gram-negative bacteria. Biotechniques 26: 824-828.
36. Morgan E, Varro R, Sepulveda H, Ember JA, Apgar J, et al. (2004) Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 110: 252-266.
37. Chen YL, Chen YS, Chan H, Tseng YH, Yang SR, et al. (2012) The use of nanoscale visible light-responsive photocatalyst TiO2-Pt for the elimination of soil-borne pathogens. PLoS One 7: e31212.
38. Chen YS, Lin HH, Hung CC, Mu JJ, Hsiao YS, et al. (2009) Phenotypic characteristics and pathogenic ability across distinct morphotypes of Burkholderia pseudomallei DT. Microbiol Immunol 53: 184-189.
39. Owen SJ, Batzloff M, Chehrehasa F, Meedeniya A, Casart Y, et al. (2009) Nasal-associated lymphoid tissue and olfactory epithelium as portals of entry for Burkholderia pseudomallei in murine melioidosis. J Infect Dis 199: 1761-1770.
40. Khan NA, Shin S, Chung JW, Kim KJ, Elliott S, et al. (2003) Outer membrane protein A and cytotoxic necrotizing factor-1 use diverse signaling mechanisms for Escherichia coli K1 invasion of human brain microvascular endothelial cells. Microb Pathog 35: 35-42.
41. Kim KS, (2006) Microbial translocation of the blood-brain barrier. Int J Parasitol 36: 607-614.
42. Shin S, Kim KS, (2010) Human brain endothelial ATP synthase beta-subunit is mannose-insensitive binding target of FimH. FEMS Microbiol Lett 303: 156-62.
43. Drevets DA, Dillon MJ, Schawang JS, Van Rooijen N, Ehrchen J, et al. (2004) The Ly-6Chigh monocyte subpopulation transports Listeria monocytogenes into the brain during systemic infection of mice. J Immunol 172: 4418-4424.
44. Drevets DA, (1999) Dissemination of Listeria monocytogenes by infected phagocytes. Infect Immun 67: 3512-3517.
45. Join-Lambert OF, Ezine S, Le Monnier A, Jaubert F, Okabe M, et al. (2005) Listeria monocytogenes-infected bone marrow myeloid cells promote bacterial invasion of the central nervous system. Cell Microbiol 7: 167-180.
46. Tan GY, Liu Y, Sivalingam SP, Sim SH, Wang D, et al. (2008) Burkholderia pseudomallei aerosol infection results in differential inflammatory responses in BALB/c and C57BL/6 mice. J Med Microbiol 57: 508-515.
47. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM, (2001) Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 193: 713-726.
48. Simpson AJ, Smith MD, Weverling GJ, Suputtamongkol Y, Angus BJ, et al. (2000) Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis. J Infect Dis 181: 621-625.
49. Ulett GC, Ketheesan N, Hirst RG, (2000) Proinflammatory cytokine mRNA responses in experimental Burkholderia pseudomallei infection in mice. Acta Trop 74: 229-234.
50. Mosser DM, (2003) The many faces of macrophage activation. J Leukoc Biol 73: 209-212.
51. Abram CL, Lowell CA, (2009) The ins and outs of leukocyte integrin signaling. Annu Rev Immunol 27: 339-362.
52. Kinashi T, (2005) Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol 5: 546-559.
53. Evans R, Patzak I, Svensson L, De Filippo K, Jones K, et al. (2009) Integrins in immunity. J Cell Sci 122: 215-225.
54. Lilius EM, Nuutila J, (2012) Bacterial infections, DNA virus infections, and RNA virus infections manifest differently in neutrophil receptor expression. ScientificWorldJournal 2012: 527347.
55. Sunderkötter C, Nikolic T, Dillon MJ, Van Rooijen N, Stehling M, et al. (2004) Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 172: 4410-4417.
56. Gordon S, Taylor PR, (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964.
57. Serbina NV, Hohl TM, Cherny M, Pamer EG, (2009) Selective expansion of the monocytic lineage directed by bacterial infection. J Immunol 183: 1900-1910.
58. Ye Z, Lee CM, Sun GW, Gan YH, (2008) Burkholderia pseudomallei infection of T cells leads to T-cell costimulation partially provided by flagellin. Infect Immun 76: 2541-2550.
59. Kleine TO, Benes L, (2006) Immune surveillance of the human central nervous system (CNS): different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons. Cytometry A 69: 147-1451.
60. Rose S, Misharin A, Perlman H, (2012) A novel Ly6C/Ly6G-based strategy to analyze the mouse splenic myeloid compartment. Cytometry A 81: 343-350.
61. Patarroyo M, (1994) Adhesion molecules mediating recruitment of monocytes to inflamed tissue. Immunobiology 191: 474-477.